v3.26.1
Condensed Combined and Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance (In shares), beginning at Dec. 31, 2024   61,507,446      
Balance beginning period at Dec. 31, 2024 $ 222,936 $ 6 $ 664,874 $ (3,356) $ (438,588)
Exercise of common stock options 14   14    
Exercise of common stock options, Shares   2,375      
Provision for pension benefit obligation 48     48  
Stock-based compensation expense 5,298   5,298    
Unrealized gain loss on available-for-sale securities (21)     (21)  
Net (loss) income 46,885       46,885
Balance end period at Mar. 31, 2025 275,160 $ 6 670,186 (3,329) (391,703)
Balance (In shares), period end at Mar. 31, 2025   61,509,821      
Balance (In shares), beginning at Dec. 31, 2024   61,507,446      
Balance beginning period at Dec. 31, 2024 222,936 $ 6 664,874 (3,356) (438,588)
Provision for pension benefit obligation 101        
Net (loss) income 34,590        
Balance end period at Jun. 30, 2025 268,080 $ 6 675,445 (3,373) (403,998)
Balance (In shares), period end at Jun. 30, 2025   61,717,349      
Balance (In shares), beginning at Dec. 31, 2024   61,507,446      
Balance beginning period at Dec. 31, 2024 222,936 $ 6 664,874 (3,356) (438,588)
Net (loss) income (38,600)        
Balance end period at Dec. 31, 2025 233,056 $ 7 714,090 (3,827) (477,214)
Balance (In shares), period end at Dec. 31, 2025   65,543,723      
Balance (In shares), beginning at Mar. 31, 2025   61,509,821      
Balance beginning period at Mar. 31, 2025 275,160 $ 6 670,186 (3,329) (391,703)
Restricted common stock vesting, Shares   112,159      
Provision for pension benefit obligation 53     53  
Stock-based compensation expense 4,894   4,894    
Unrealized gain loss on available-for-sale securities (97)     (97)  
Issuance of shares under employee stock purchase plan, Shares   95,369      
Issuance of shares under employee stock purchase plan 365   365    
Net (loss) income (12,295)       (12,295)
Balance end period at Jun. 30, 2025 268,080 $ 6 675,445 (3,373) (403,998)
Balance (In shares), period end at Jun. 30, 2025   61,717,349      
Balance (In shares), beginning at Dec. 31, 2025   65,543,723      
Balance beginning period at Dec. 31, 2025 233,056 $ 7 714,090 (3,827) (477,214)
Restricted common stock vesting, Shares   186,515      
Exercise of pre-funded warrants   5,016,628      
Exercise of common stock options 4,522   4,522    
Exercise of common stock options, Shares   574,839      
Provision for pension benefit obligation 55     55  
Stock-based compensation expense 5,949   5,949    
Unrealized gain loss on available-for-sale securities (974)     (974)  
Issuance of common stock, Share   13,000,000      
Issuance of common stock 323,811 $ 1 323,810    
Net (loss) income (44,503)       (44,503)
Balance end period at Mar. 31, 2026 521,916 $ 8 1,048,371 (4,746) (521,717)
Balance (In shares), period end at Mar. 31, 2026   84,321,705      
Balance (In shares), beginning at Dec. 31, 2025   65,543,723      
Balance beginning period at Dec. 31, 2025 $ 233,056 $ 7 714,090 (3,827) (477,214)
Exercise of common stock options, Shares 921,552        
Provision for pension benefit obligation $ 109        
Net (loss) income (87,900)        
Balance end period at Jun. 30, 2026 487,281 $ 9 1,057,551 (5,165) (565,114)
Balance (In shares), period end at Jun. 30, 2026   85,226,427      
Balance (In shares), beginning at Mar. 31, 2026   84,321,705      
Balance beginning period at Mar. 31, 2026 521,916 $ 8 1,048,371 (4,746) (521,717)
Restricted common stock vesting, Shares   1,749      
Exercise of pre-funded warrants   509,300      
Exercise of pre-funded warrants, Amount   $ 1 (1)    
Exercise of common stock options 2,600   2,600    
Exercise of common stock options, Shares   346,713      
Provision for pension benefit obligation 54     (54)  
Stock-based compensation expense 5,970   5,970    
Unrealized gain loss on available-for-sale securities $ 473     (473)  
Issuance of shares under employee stock purchase plan, Shares 46,960        
Issuance of shares under employee stock purchase plan $ 611   611    
Net (loss) income (43,397)       (43,397)
Balance end period at Jun. 30, 2026 $ 487,281 $ 9 $ 1,057,551 $ (5,165) $ (565,114)
Balance (In shares), period end at Jun. 30, 2026   85,226,427